Diabetes impairs activity of bone stem cells in mice, inhibits fracture repair

January 11, 2017
Credit: Martha Sexton/public domain

Bone fractures in diabetic mice heal better in the presence of a protein that stimulates the activity of skeletal stem cells, according to a study by researchers at the Stanford University School of Medicine.

The protein counteracts a decrease in stem cell activity that the researchers observed both in mouse models of diabetes and in samples from diabetic patients who had undergone joint replacements. The researchers hope the discovery will lead to ways to help people with diabetes heal more efficiently from broken bones.

"We've uncovered the reason why some patients with diabetes don't heal well from fractures, and we've come up with a solution that can be locally applied during surgery to repair the break," said Michael Longaker, MD, co-director of Stanford's Institute for Stem Cell Biology and Regenerative Medicine. "Diabetes is rampant worldwide, and any improvement in the ability of affected people to heal from fractures could have an enormously positive effect on their quality of life."

The study will be published Jan. 11 in Science Translational Medicine. Longaker, a professor of plastic and reconstructive surgery, shares senior authorship of the study with Charles Chan, PhD, an instructor at the stem cell institute. Postdoctoral scholar Ruth Tevlin, MD, is the lead author.

Healing difficulties

Diabetes mellitus is a metabolic disease characterized by the inability to either produce or to respond appropriately to insulin. It affects hundreds of millions of people worldwide and is increasing in prevalence. In addition to causing dangerous swings in blood sugar levels after meals, the condition leads to many other debilitating symptoms, including an impaired ability to heal soft tissue injuries and skeletal fractures. The precise molecular reason behind this impaired has been unknown, however.

Longaker, Chan and Tevlin built on previous research in which they and colleagues in the laboratory of co-author Irving Weissman, MD, professor of pathology and of developmental biology, identified and described a population of cells in the bones of mice that serve as skeletal stem cells, or SSCs. These can become all components of the skeletal system, including bone, cartilage and a part of the bone marrow known as the stroma. They subsequently showed that fracture healing in mice was severely impaired when these stem cells were depleted. That finding got them thinking.

"We wanted to apply what we knew about to the problem of impaired bone healing in people with diabetes," said Chan. "Does the disease affect fracture healing by somehow modulating the activity of these stem cells?"

The researchers used a mouse model of Type 2 diabetes, in which the disease arises when the animals are about 4 weeks old. Prior to the development of the disease, the prediabetic mice were able to heal leg bone fractures as effectively as wild-type mice, the researchers found. In contrast, after the disease had manifested itself, the repaired bone was significantly weaker and less dense than the bone in the control animals. When they compared the numbers of SSCs in the healing bone seven days after fracture, they found that the had significantly lower numbers of these cells than did the control animals.

Signaling problem

A series of experiments ruled out a systemic reason for this reduction in stem cell numbers, and also confirmed that the cells themselves were fully functional. That left only a potential problem with the signals the cells were receiving from the surrounding environment, or niche. When Tevlin and her colleagues analyzed that environment, they found that the diabetic animals produced significantly lower levels of a family of signaling proteins called hedgehog that are known to play a critical role in many biological processes, including embryonic development and tissue regeneration.

The researchers collaborated with co-author Philip Beachy, PhD, professor of biochemistry and of developmental biology, to test whether artificially blocking the hedgehog signaling pathway could impair bone healing in nondiabetic mice. They found that control mice exposed to a molecule that blocked the pathway regrew bone that was weaker and more brittle—just like the diabetic animals.

"Next we had to test whether adding the hedgehog signaling proteins back into the local environment in diabetic animals restored their ability to heal fractures," said Longaker. The researchers collaborated with co-authors Fan Yang, PhD, assistant professor of bioengineering and orthopaedic surgery, and postdoctoral scholar Xinming Tong, PhD, to devise a biologically friendly hydrogel into which the hedgehog signaling proteins were embedded. The gel was applied directly to the fracture site. "And these animals healed just like normal mice," said Longaker, who holds the Deane P. and Louise Mitchell Professorship in the School of Medicine.

Clues in human bone samples

Finally, the team reached out to co-author Stuart Goodman, MD, PhD, professor of orthopaedic surgery, to obtain bone samples from patients with diabetes who were undergoing joint replacement for osteoarthritis. They compared the expression of proteins important to the hedgehog signaling pathway from these samples with others obtained from non-diabetic patients. Normally this tissue would be discarded by the surgeon, but in this case it held important clues.

"What we saw in these human samples completely echoed what we saw in the mice," said Chan. "The bones from the diabetic patients displayed significantly reduced expression of these important signaling proteins."

Longaker, Chan and Tevlin believe the inhibition of the hedgehog signaling pathway arises from diabetes-associated inflammation that causes high levels of a molecule called tumor necrosis factor alpha. TNF-alpha levels are known to be elevated in patients with diabetes, and the researchers observed a corresponding increase in their mouse models of the disease. They also showed that these increased levels of TNF-alpha inhibited the expression of some hedgehog family members. Directly inhibiting all TNF-alpha activity, however, could have other dire consequences for an animal or a human patient because TNF-alpha plays many important biological roles.

"Here we've devised a feasible strategy for reversing a tissue-specific pathology—the inability to heal skeletal fractures efficiently—in a complex metabolic disease like diabetes, through the local application of a compound to stimulate the activity of adult stem cells," said Longaker said. "We anticipate that hedgehog-mediated molecular therapies that directly target stem cells in human patients could be therapeutic."

More research is necessary before trying this approach in humans, but the researchers are hopeful that local application of hedgehog proteins will be shown to be both safe and effective. Their findings further validate the idea that tissue-specific stem cells are likely to play vital roles in tissue regeneration and response to injury.

"This research represents a significant step forward toward realizing the promise of Proposition 71, which established the California Institute for Regenerative Medicine," said Chan. "We've looked to to learn why people with don't heal bone fractures properly, and come up with an approach that we are excited to try in the clinic."

Explore further: Team isolates stem cell that gives rise to bones, cartilage in mice

More information: "Pharmacological rescue of diabetic skeletal stem cell niches," Science Translational Medicine, stm.sciencemag.org/lookup/doi/ … scitranslmed.aag2809

Related Stories

Team isolates stem cell that gives rise to bones, cartilage in mice

January 15, 2015
Researchers at the Stanford University School of Medicine have discovered the stem cell in mice that gives rise to bone, cartilage and a key part of bone marrow called the stroma.

Amphibian approach to help bones heal faster and better

November 19, 2015
Inspired by amphibians like salamanders, researchers from the University of Southampton are developing a new type of drug that may help bones heal faster and better.

Repair cartilage potentially can heal horribly broken bones

May 11, 2016
Stem cells could one day be stimulated to make a special type of cartilage to help repair large, hard-to-heal bone fractures – a potential boon for doctors treating big-money athletes, USC researchers say.

Key regulator of bone development identified

December 8, 2016
Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Regenerative stem cell active in human blood vessels could help patients with diabetes and cardiovascular disease

December 20, 2016
The discovery of a regenerative stem cell active in human blood vessels could help patients with diabetes and cardiovascular disease.

Stem cell treatment may offer option for broken bones that don't heal

June 5, 2011
Researchers at the University of North Carolina at Chapel Hill School of Medicine have shown in an animal study that transplantation of adult stem cells enriched with a bone-regenerating hormone can help mend bone fractures ...

Recommended for you

Researchers find infectious prions in Creutzfeldt-Jakob disease patient skin

November 22, 2017
Creutzfeldt-Jakob disease (CJD)—the human equivalent of mad cow disease—is caused by rogue, misfolded protein aggregates termed prions, which are infectious and cause fatal damages in the patient's brain. CJD patients ...

Surprising roles for muscle in tissue regeneration, study finds

November 22, 2017
A team of researchers at Whitehead has illuminated an important role for different subtypes of muscle cells in orchestrating the process of tissue regeneration. In a paper published in the November 22 issue of Nature, they ...

Study reveals new mechanisms of cell death in neurodegenerative disorders

November 22, 2017
Researchers at King's College London have discovered new mechanisms of cell death, which may be involved in debilitating neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease.

How rogue immune cells cross the blood-brain barrier to cause multiple sclerosis

November 21, 2017
Drug designers working on therapeutics against multiple sclerosis should focus on blocking two distinct ways rogue immune cells attack healthy neurons, according to a new study in the journal Cell Reports.

New simple test could help cystic fibrosis patients find best treatment

November 21, 2017
Several cutting-edge treatments have become available in recent years to correct the debilitating chronic lung congestion associated with cystic fibrosis. While the new drugs are life-changing for some patients, they do not ...

Researchers discover key signaling protein for muscle growth

November 20, 2017
Researchers at the University of Louisville have discovered the importance of a well-known protein, myeloid differentiation primary response gene 88 (MyD88), in the development and regeneration of muscles. Ashok Kumar, Ph.D., ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.